SEC Form 4 · accession 0000899243-17-006160
APPLIED GENETIC TECHNOLOGIES CORP · AGTC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott Koenig
Director
Period of report
Feb 28, 2017
Accepted (ET)
Mar 2, 2017 · 7:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001273636
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $7.75 | Feb 28, 2017 | A | 8,000 | A | — | Feb 28, 2027 | Common Stock | 8,000 | 8,000 | D |
Explanation of responses
- F1Option becomes exercisable on February 28, 2018.